Commemorating 100 years of immunotherapyMechanisms of allergen-specific immunotherapy
Section snippets
Very early mast cell and basophil suppression–related desensitization effect
Although decreases in IgE antibody levels and IgE-mediated skin sensitivity normally require years of SIT, most patients are protected against bee stings or tolerate skin late-phase response challenges at early stages of respective venom or grass pollen SIT.41, 42 An important observation starting from the first injection is an early decrease in mast cell and basophil activity for degranulation and systemic anaphylaxis (Fig 1). There is surprisingly little information about the mechanisms by
Conclusion
Allergen SIT and high-dose allergen exposure models represent efficient tools for the understanding of the mechanisms of action of curative treatment of allergic diseases and now enlighten the complex interactions of effector cells with tissues and Treg cells. In addition to allergy, these mechanisms might have implications in autoimmunity, organ transplant tolerance, tumor cell growth, parasite survival/clearance, and chronic infections. Suppression of an immune response by TR1 or FOXP3+ Treg
References (131)
Allergy and hypersensitivity: mechanisms of allergic disease
Curr Opin Immunol
(2006)Healthy immune response to allergens: T regulatory cells and more
Curr Opin Immunol
(2006)- et al.
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)
J Allergy Clin Immunol
(2002) - et al.
IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis
J Allergy Clin Immunol
(2006) - et al.
Increased IL-33 expression by epithelial cells in bronchial asthma
J Allergy Clin Immunol
(2010) - et al.
IL-33-activated dendritic cells induce an atypical TH2-type response
J Allergy Clin Immunol
(2009) Immunologic influences on allergy and the TH1/TH2 balance
J Allergy Clin Immunol
(2004)- et al.
T cells and eosinophils cooperate in the induction of bronchial epithelial apoptosis in asthma
J Allergy Clin Immunol
(2002) - et al.
Histamine receptors are hot in immunopharmacology
Eur J Pharmacol
(2006) - et al.
Novel vaccines and adjuvants for allergen-specific immunotherapy
Curr Opin Immunol
(2006)
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy
J Allergy Clin Immunol
Modulation of allergen-specific T-lymphocyte function by virus-like particles decorated with HLA class II molecules
J Allergy Clin Immunol
Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy
J Allergy Clin Immunol
Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease
Lancet
IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1
J Allergy Clin Immunol
IL-10 suppresses CD2-mediated T cell activation via SHP-1
Mol Immunol
Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1
Blood
Current mite, cat, and dog allergen exposure, pet ownership, and sensitization to inhalant allergens in adults
J Allergy Clin Immunol
Association between CD4(+)CD25(high) T cells and atopy in children
J Allergy Clin Immunol
Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals
J Allergy Clin Immunol
Circulating Foxp3+CD4+ cell numbers in atopic patients and healthy control subjects
J Allergy Clin Immunol
Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study
J Allergy Clin Immunol
Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy
J Allergy Clin Immunol
Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy
J Allergy Clin Immunol
Allergen-specific immunotherapy with recombinant grass pollen allergens
J Allergy Clin Immunol
Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity
J Allergy Clin Immunol
Therapeutic manipulation of immune tolerance in allergic disease
Nat Rev Drug Discov
Mechanisms of allergen-specific immunotherapy
J Allergy Clin Immunol
Immunological mechanisms of allergen-specific immunotherapy
Nat Rev Immunol
Long-term clinical efficacy of grass-pollen immunotherapy
N Engl J Med
Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study
Clin Exp Allergy
Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway
J Allergy Clin Immunol
T(H)2 adjuvants: implications for food allergy
J Allergy Clin Immunol
T-cell effector pathways in allergic diseases: transcriptional mechanisms and therapeutic targets
J Allergy Clin Immunol
Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles
Am J Respir Cell Mol Biol
IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells
J Exp Med
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
Nat Immunol
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Nat Rev Drug Discov
Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet
Science
Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases
J Allergy Clin Immunol
T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis
J Clin Invest
IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis
J. Allergy Clin Immunol
T cells and eosinophils in bronchial smooth muscle cell death in asthma
Clin Exp Allergy
Differentiation and functional analysis of human T(H)17 cells
J Allergy Clin Immunol
Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Nature
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Nat Immunol
Transforming growth factor-beta induces development of the T(H)17 lineage
Nature
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
Nat Immunol
Regulation and characterization of IL-17A expression in patients with chronic rhinosinusitis and its relationship with eosinophilic inflammation
J Allergy Clin Immunol
The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity
J Allergy Clin Immunol
Cited by (0)
Series editors: Joshua A. Boyce, MD, Fred Finkelman, MD, William T. Shearer, MD, PhD, and Donata Vercelli, MD
Supported by the Swiss National Foundation grants 320030_125249/1 and 320030_132899 and the Christine Kühne Center for Allergy Research and Education (CK-CARE).
Terms in boldface and italics are defined in the glossary on page 19.